5451 - 5475 of 8471 Results
Title
Year
- Miro1 Marks Parkinson’s Disease Subset and Miro1 Reducer Rescues Neuron Loss in Parkinson’s Models2019OPENTitle: Miro1 Marks Parkinson’s Disease Subset and Miro1 Reducer Rescues Neuron Loss in Parkinson’s ModelsJournal Name: Cell MetabolismPublisher: Elsevier BVVol: 30Issue #: 6Start Page: 1131End Page: 1140.e7Publication Date:Open Access(OA) Status: OPENLicense: other-oaDOI - Digital Object Identifier: 10.1016/j.cmet.2019.08.023Best OA location URL: http://www.cell.com/article/S1550413119304978/pdfCitation Count: 134
-
OPENTitle: Apoptosis signal regulating kinase 1 deletion mitigates α-synuclein pre-formed fibril propagation in miceJournal Name: Neurobiology of AgingPublisher: Elsevier BVVol: 85Issue #:Start Page: 49End Page: 57Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.neurobiolaging.2019.09.012Best OA location URL: https://europepmc.org/articles/pmc7064162?pdf=renderCitation Count: 14
-
OPENTitle: Feasibility and utility of a clinician dashboard from wearable and mobile application Parkinson’s disease dataJournal Name: npj Digital MedicinePublisher: Springer Science and Business Media LLCVol: 2Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41746-019-0169-yBest OA location URL: https://www.nature.com/articles/s41746-019-0169-y.pdfCitation Count: 57
-
OPENTitle: Levels of Oligomeric α-Synuclein in Reflex Tears Distinguish Parkinson'S Disease Patients From Healthy ControlsJournal Name: Biomarkers in MedicinePublisher: Informa UK LimitedVol: 13Issue #: 17Start Page: 1447End Page: 1457Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.2217/bmm-2019-0315Best OA location URL: https://www.futuremedicine.com/doi/pdf/10.2217/bmm-2019-0315Citation Count: 32
-
RESTRICTEDTitle: Physiotherapy improves motor function in patients with the Parkinson variant of multiple system atrophy: A prospective trialJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 67Issue #:Start Page: 60End Page: 65Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2019.09.026Citation Count: 31
-
OPENTitle: Development of a Disease Progression Model for Leucine‐Rich Repeat Kinase 2 in Parkinson's Disease to Inform Clinical Trial DesignsJournal Name: Clinical Pharmacology & TherapeuticsPublisher: WileyVol: 107Issue #: 3Start Page: 553End Page: 562Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/cpt.1634Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/7939141Citation Count: 17
-
OPENTitle: Machine learning for comprehensive forecasting of Alzheimer’s Disease progressionJournal Name: Scientific ReportsPublisher: Springer Science and Business Media LLCVol: 9Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41598-019-49656-2Best OA location URL: https://www.nature.com/articles/s41598-019-49656-2.pdfCitation Count: 167
-
OPENTitle: Quadruple Decision Making for Parkinson’s Disease Patients: Combining Expert Opinion, Patient Preferences, Scientific Evidence, and Big Data Approaches to Reach Precision MedicineJournal Name: Journal of Parkinson’s DiseasePublisher: SAGE PublicationsVol: 10Issue #: 1Start Page: 223End Page: 231Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.3233/jpd-191712Best OA location URL: https://content.iospress.com:443/download/journal-of-parkinsons-disease/jpd191712?id=journal-of-parkinsons-disease%2Fjpd191712Citation Count: 28
-
RESTRICTEDTitle: How to evaluate effects of occupational therapy – lessons learned from an exploratory randomized controlled trialJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 67Issue #:Start Page: 42End Page: 47Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2019.09.013Citation Count: 4
-
RESTRICTEDTitle: Applications of amyloid, tau, and neuroinflammation PET imaging to Alzheimer's disease and mild cognitive impairmentJournal Name: Human Brain MappingPublisher: WileyVol: 40Issue #: 18Start Page: 5424End Page: 5442Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.1002/hbm.24782Best OA location URL: https://europepmc.org/articles/pmc6864887?pdf=renderCitation Count: 130
-
OPENTitle: mTOR hyperactivity mediates lysosomal dysfunction in Gaucher's disease iPSC-neuronal cellsJournal Name: Disease Models & MechanismsPublisher: The Company of BiologistsVol: 12Issue #: 10Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1242/dmm.038596Best OA location URL: https://dmm.biologists.org/content/dmm/12/10/dmm038596.full.pdfCitation Count: 58
-
OPENTitle: Microscopic Viscosity of Neuronal Plasma Membranes Measured Using Fluorescent Molecular Rotors: Effects of Oxidative Stress and NeuroprotectionJournal Name: ACS Applied Materials & InterfacesPublisher: American Chemical Society (ACS)Vol: 11Issue #: 40Start Page: 36307End Page: 36315Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1021/acsami.9b10426Best OA location URL: https://hdl.handle.net/10044/1/73521Citation Count: 48
-
OPENTitle: Proceedings of the Sixth Deep Brain Stimulation Think Tank Modulation of Brain Networks and Application of Advanced Neuroimaging, Neurophysiology, and OptogeneticsJournal Name: Frontiers in NeurosciencePublisher: Frontiers Media SAVol: 13Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fnins.2019.00936Best OA location URL: https://www.frontiersin.org/articles/10.3389/fnins.2019.00936/pdfCitation Count: 32
-
OPENTitle: Genomewide association study of Parkinson's disease clinical biomarkers in 12 longitudinal patients' cohortsJournal Name: Movement DisordersPublisher: WileyVol: 34Issue #: 12Start Page: 1839End Page: 1850Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.27845Best OA location URL: http://hdl.handle.net/20.500.11820/51a559a5-38a4-4a09-a501-6c78ddefb3fdCitation Count: 146
-
OPENTitle: Higher Urine bis(Monoacylglycerol)Phosphate Levels in LRRK2 G2019S Mutation Carriers: Implications for Therapeutic DevelopmentJournal Name: Movement DisordersPublisher: WileyVol: 35Issue #: 1Start Page: 134End Page: 141Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1002/mds.27818Best OA location URL: https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fmds.27818Citation Count: 69
-
OPENTitle: Transportation innovation to aid Parkinson disease trial recruitmentJournal Name: Contemporary Clinical Trials CommunicationsPublisher: Elsevier BVVol: 16Issue #:Start Page: 100449End Page: 100449Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.conctc.2019.100449Best OA location URL: https://doi.org/10.1016/j.conctc.2019.100449Citation Count: 8
- Intrastriatal alpha-synuclein fibrils in monkeys: spreading, imaging and neuropathological changes2019OPENTitle: Intrastriatal alpha-synuclein fibrils in monkeys: spreading, imaging and neuropathological changesJournal Name: BrainPublisher: Oxford University Press (OUP)Vol: 142Issue #: 11Start Page: 3565End Page: 3579Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1093/brain/awz296Best OA location URL: https://academic.oup.com/brain/article-pdf/142/11/3565/36604650/awz296.pdfCitation Count: 97
- PDkit2019RESTRICTEDTitle: PDkitJournal Name: Adjunct Proceedings of the 2019 ACM International Joint Conference on Pervasive and Ubiquitous Computing and Proceedings of the 2019 ACM International Symposium on Wearable ComputersPublisher: ACMVol:Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1145/3341162.3346277Citation Count: 1
-
OPENTitle: The kainate receptor antagonist UBP310 but not single deletion of GluK1, GluK2, or GluK3 subunits, inhibits MPTP-induced degeneration in the mouse midbrainJournal Name: Experimental NeurologyPublisher: Elsevier BVVol: 323Issue #:Start Page: 113062End Page: 113062Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.expneurol.2019.113062Best OA location URL: https://opus.lib.uts.edu.au/bitstream/10453/136564/4/Binder1.pdfCitation Count: 14
- Deep brain stimulation and genetic variability in Parkinson’s disease: a review of the literature2019RESTRICTEDTitle: Deep brain stimulation and genetic variability in Parkinson’s disease: a review of the literatureJournal Name: npj Parkinson's DiseasePublisher: Springer Science and Business Media LLCVol: 5Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41531-019-0091-7Best OA location URL: https://www.nature.com/articles/s41531-019-0091-7.pdfCitation Count: 23
-
OPENTitle: Sex differences by design and outcome in the Safety of Urate Elevation in PD (SURE-PD) trialJournal Name: NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 93Issue #: 14Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1212/wnl.0000000000008194Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6814412Citation Count: 39
-
OPENTitle: Unified Staging System for Lewy Body Disorders: Clinicopathologic Correlations and Comparison to Braak StagingJournal Name: Journal of Neuropathology & Experimental NeurologyPublisher: Oxford University Press (OUP)Vol: 78Issue #: 10Start Page: 891End Page: 899Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1093/jnen/nlz080Best OA location URL: https://academic.oup.com/jnen/article-pdf/78/10/891/30026987/nlz080.pdfCitation Count: 69
- Neuronal vulnerability in Parkinson disease: Should the focus be on axons and synaptic terminals?2019RESTRICTEDTitle: Neuronal vulnerability in Parkinson disease: Should the focus be on axons and synaptic terminals?Journal Name: Movement DisordersPublisher: WileyVol: 34Issue #: 10Start Page: 1406End Page: 1422Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.27823Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6879792Citation Count: 68
-
RESTRICTEDTitle: Understanding the Links Between Cardiovascular Disease and Parkinson's DiseaseJournal Name: Movement DisordersPublisher: WileyVol: 35Issue #: 1Start Page: 55End Page: 74Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.27836Best OA location URL: https://europepmc.org/articles/pmc6981000?pdf=renderCitation Count: 83
-
RESTRICTEDTitle: What’s the target: understanding two decades of in silico microRNA-target predictionJournal Name: Briefings in BioinformaticsPublisher: Oxford University Press (OUP)Vol: 21Issue #: 6Start Page: 1999End Page: 2010Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1093/bib/bbz111Citation Count: 50